222 related articles for article (PubMed ID: 25192252)
1. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia.
Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
PLoS One; 2014; 9(9):e106838. PubMed ID: 25192252
[TBL] [Abstract][Full Text] [Related]
2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis.
Zhang M; Zhang W; Liao H
Respir Med Res; 2024 Jun; 85():101096. PubMed ID: 38744231
[TBL] [Abstract][Full Text] [Related]
4. [Glucocorticoide therapy in premature infants: French practices in 2006].
Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
[TBL] [Abstract][Full Text] [Related]
5. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2012 Apr; (4):CD002311. PubMed ID: 22513906
[TBL] [Abstract][Full Text] [Related]
6. Inhaled hydrofluoalkane-beclomethasone dipropionate in bronchopulmonary dysplasia. A double-blind, randomized, controlled pilot study.
Kugelman A; Peniakov M; Zangen S; Shiff Y; Riskin A; Iofe A; Shoris I; Bader D; Arnon S
J Perinatol; 2017 Feb; 37(2):197-202. PubMed ID: 27735931
[TBL] [Abstract][Full Text] [Related]
7. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
Bauer J; Beedgen B; Böhler T; Sontheimer D; Zilow EP; Linderkamp O
Klin Padiatr; 1996; 208(2):56-60. PubMed ID: 8901183
[TBL] [Abstract][Full Text] [Related]
8. Inhaled budesonide for the prevention of bronchopulmonary dysplasia.
Bassler D
J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2372-2374. PubMed ID: 27756156
[TBL] [Abstract][Full Text] [Related]
9. Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study.
Denjean A; Paris-Llado J; Zupan V; Debillon T; Kieffer F; Magny JF; Desfrères L; Llanas B; Guimaraes H; Moriette G; Voyer M; Dehan M; Breart G
Eur J Pediatr; 1998 Nov; 157(11):926-31. PubMed ID: 9835439
[TBL] [Abstract][Full Text] [Related]
10. Inhaled bronchodilator use for infants with bronchopulmonary dysplasia.
Slaughter JL; Stenger MR; Reagan PB; Jadcherla SR
J Perinatol; 2015 Jan; 35(1):61-6. PubMed ID: 25102319
[TBL] [Abstract][Full Text] [Related]
11. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
[TBL] [Abstract][Full Text] [Related]
12. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.
Cole CH; Colton T; Shah BL; Abbasi S; MacKinnon BL; Demissie S; Frantz ID
N Engl J Med; 1999 Apr; 340(13):1005-10. PubMed ID: 10099142
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Corticosteroid Exposure in Hospitalized Infants with Bronchopulmonary Dysplasia.
Leiting C; Kerns E; Euteneuer JC; McCulloh RJ; Peeples ES
Am J Perinatol; 2024 May; 41(S 01):e85-e93. PubMed ID: 35523409
[TBL] [Abstract][Full Text] [Related]
14. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
[TBL] [Abstract][Full Text] [Related]
15. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
[TBL] [Abstract][Full Text] [Related]
16. Meter-dosed, inhaled beclomethasone attenuates bronchoalveolar oxyradical inflammation in premature infants at risk for bronchopulmonary dysplasia.
Zimmerman JJ; Gabbert D; Shivpuri C; Kayata S; Ciesielski W; Miller J; Peters ME; Eissenstat RP; Shen G
Am J Perinatol; 1998; 15(10):567-76. PubMed ID: 9926878
[TBL] [Abstract][Full Text] [Related]
17. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2012 May; (5):CD002058. PubMed ID: 22592683
[TBL] [Abstract][Full Text] [Related]
18. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2007 Oct; (4):CD002057. PubMed ID: 17943765
[TBL] [Abstract][Full Text] [Related]
19. Drug treatment for bronchopulmonary dysplasia in Japan: questionnaire survey.
Ogawa R; Mori R; Sako M; Kageyama M; Tamura M; Namba F
Pediatr Int; 2015; 57(1):189-92. PubMed ID: 25711265
[TBL] [Abstract][Full Text] [Related]
20. Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia.
Bassler D; Plavka R; Shinwell ES; Hallman M; Jarreau PH; Carnielli V; Van den Anker JN; Meisner C; Engel C; Schwab M; Halliday HL; Poets CF;
N Engl J Med; 2015 Oct; 373(16):1497-506. PubMed ID: 26465983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
